Sabater E, López-Guillermo A, Rueda A, Salar A, Oyagüez I, Collar JM
Cost-effectiveness analysis of bendamustine plus rituximab as a first-line treatment for patients with follicular lymphoma in Spain
Appl Health Econ Health Policy 2016;14(4):465-77
Grau S, Lozano V, Valladares A, Cavanillas R, Xie Y, Nocea G
Impact of dynamic microbiological environment on the clinical efficacy of ertapenem and piperacillin/tazobactam in the treatment of complicated community-acquired intra-abdominal infection in Spain: A cost-consequence analysis
Appl Health Econ Health Policy. 2015;13(4):369-79
Roman A, Barberà JA, Escribano P, Sala ML, Febrer L, Oyagüez I, Sabater E, Casado MA
Cost effectiveness of prostacyclins in pulmonary arterial hypertension
Appl Health Econ Health Policy. 2012;10(3):175-88
Orofino J, Soto J, Casado MA, Oyagüez I